CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · Real-Time Price · USD
0.3249
-0.0139 (-4.10%)
At close: Aug 10, 2026, 4:00 PM EDT
0.3299
+0.0050 (1.54%)
After-hours: Aug 10, 2026, 5:39 PM EDT
CollPlant Biotechnologies Market Cap
CollPlant Biotechnologies has a market cap or net worth of $6.14 million as of August 10, 2026. Its market cap has decreased by -80.62% in one year.
Market Cap
6.14M
Enterprise Value
4.53M
1-Year Change
-80.62%
Ranking
Category
Stock Price
$0.32
ChartMarket Cap Chart
Since January 31, 2018, CollPlant Biotechnologies's market cap has decreased from $30.60M to $6.14M, a decrease of -79.92%. That is a compound annual growth rate of -17.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 4.90M | -72.63% |
| Dec 31, 2025 | 17.90M | -56.55% |
| Dec 31, 2024 | 41.20M | -43.72% |
| Dec 29, 2023 | 73.20M | -20.95% |
| Dec 30, 2022 | 92.60M | -47.06% |
| Dec 31, 2021 | 174.90M | 147.03% |
| Dec 31, 2020 | 70.80M | 226.27% |
| Dec 31, 2019 | 21.70M | 55.00% |
| Dec 31, 2018 | 14.00M | -54.25% |
| Jan 31, 2018 | 30.60M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ensysce Biosciences | 6.39M |
| PharmaCyte Biotech | 6.23M |
| Purple Biotech | 6.10M |
| Pulmatrix | 5.95M |
| NuCana | 5.93M |
| GeoVax Labs | 5.89M |
| AIM ImmunoTech | 5.77M |
| Addex Therapeutics | 5.75M |